Related Experiment Video
Updated: Aug 30, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
The adenine nucleotide translocator: a new potential chemotherapeutic target
Anne-Sophie Belzacq1, Catherine Brenner
1Centre National de la Recherche Scientifique, UMR 6022, Université de Technologie de Compiègne, 60205 Compiègne, France.
Abstract:
Identification of new targets is of utmost importance for the development of efficient apoptosis-modulating drugs. This has become possible from the unraveling of the basic apoptosis mechanisms and notably, from the demonstration of the mitochondrial membrane permeabilization as a central rate-limiting step of numerous models of cell death. Indeed, molecular and pharmacological studies revealed that the adenine nucleotide translocator (ANT) could be a therapeutic target. First, ANT is a bi-functional protein. It mediates the exchange of cytosolic ADP and mitochondrial ATP, and contributes to apoptosis via its capacity to become a lethal pore. Second, both ANT functions are under the control of the (anti)-oncogenes from the Bax/Bcl-2 family, and third, agents as diverse as proteins, lipids, ions, pro-oxidants or chemotherapeutic agents directly modulate the pore-forming activity of ANT. Here, we will review the mode of apoptosis induction by various classes of chemotherapeutic agents, which all influence directly ANT pro-apoptotic function. Hopefully, this will yield several clues to the modulation of apoptosis from a therapeutic perspective.
Insights
Identifying new drug targets is crucial for apoptosis modulation. The adenine nucleotide translocator (ANT) protein is a key target, influencing cell death through its pore-forming activity and interaction with cancer genes.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Apoptosis (programmed cell death) is a critical biological process.
- Mitochondrial membrane permeabilization is a central event in many cell death pathways.
- Identifying novel therapeutic targets for apoptosis modulation is essential for drug development.
Purpose of the Study:
- To review the role of the adenine nucleotide translocator (ANT) as a therapeutic target in apoptosis.
- To explore how various chemotherapeutic agents modulate ANT's pro-apoptotic function.
- To provide insights into the therapeutic modulation of apoptosis.
Main Methods:
- Review of molecular and pharmacological studies on ANT.
- Analysis of ANT's bi-functional role: nucleotide exchange and pore formation.
- Examination of ANT's regulation by Bax/Bcl-2 family proteins.
- Investigation of direct modulation of ANT pore activity by diverse agents.
Main Results:
- The adenine nucleotide translocator (ANT) is a validated therapeutic target due to its dual function.
- ANT mediates ADP/ATP exchange and contributes to cell death via pore formation.
- ANT's function is regulated by oncogenes and directly modulated by chemotherapeutic agents, pro-oxidants, and other molecules.
Conclusions:
- ANT's critical role in apoptosis makes it a promising target for drug development.
- Understanding how chemotherapeutics target ANT's pro-apoptotic function offers therapeutic strategies.
- Modulating ANT activity presents a viable approach for developing novel apoptosis-modulating drugs.
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
ABC Transporters: Exporter
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types: